Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

5.62
Delayed Data
As of Jun 24
 -0.26 / -4.42%
Today’s Change
4.25
Today|||52-Week Range
26.80
-35.48%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close5.88
Today’s open5.47
Day’s range5.33 - 5.74
Volume327,792
Average volume (3 months)309,797
Market cap$226.0M
Dividend yield--
Data as of 3:59pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+4.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+20.00%
P/E ratioNM
Price/Sales70.04
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.34-4.86%
HSKAHeska Corp+1.08+3.13%
MNOVMediciNova Inc-0.11-1.55%
CNCEConcert Pharmaceutic...-0.63-5.57%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$4.6M
Annual profit (last year)-$45.8M
Net profit margin-998.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Operating Officer &
Executive Vice President
Jeffrey Su
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs